People
Linda Lorenat focuses on general corporate and securities law matters and transactions, particularly for emerging growth companies in the technology and life sciences industries. As a partner in our Mergers & Acquisitions practice, Linda represents entrepreneurs and emerging growth companies, the investors who fund them and the investment banks and the financial advisors who advise them.
Linda represents issuers and venture capital and strategic investors in the initial formation, financing and sale of technology and life sciences companies. Linda's experience with general company representation also includes advising on employment and equity compensation matters, fiduciary duties, commercial agreements and compliance with federal and state securities laws. Her corporate transactional experience includes representing issuers and investors in convertible debt and preferred stock financings, mergers and acquisitions, public offerings and financings, recapitalizations, spin-outs and strategic transactions.
In 2016, Legal 500 recognized Linda in the category of M&A/Corporate and Commercial—Venture Capital and Emerging Companies.
J.D., Santa Clara University School of Law
B.A., Santa Clara University
California
March 30, 2022
Eleanor Health Holdings Completes $50 million Series C Financing
January 19, 2022
King & Spalding Advises on Islamic Finance News’ 2021 Cross-Border and UAE Deal of the Year
March 30, 2022
Eleanor Health Holdings Completes $50 million Series C Financing
January 19, 2022
King & Spalding Advises on Islamic Finance News’ 2021 Cross-Border and UAE Deal of the Year
March 30, 2022
Eleanor Health Holdings Completes $50 million Series C Financing
January 19, 2022
King & Spalding Advises on Islamic Finance News’ 2021 Cross-Border and UAE Deal of the Year
J.D., Santa Clara University School of Law
B.A., Santa Clara University
California